183 related articles for article (PubMed ID: 27002150)
21. LKB1/AMPK and PKA control ABCB11 trafficking and polarization in hepatocytes.
Homolya L; Fu D; Sengupta P; Jarnik M; Gillet JP; Vitale-Cross L; Gutkind JS; Lippincott-Schwartz J; Arias IM
PLoS One; 2014; 9(3):e91921. PubMed ID: 24643070
[TBL] [Abstract][Full Text] [Related]
22. Epigallocatechin Gallate Inhibits Hepatic Glucose Production in Primary Hepatocytes via Downregulating PKA Signaling Pathways and Transcriptional Factor FoxO1.
Li X; Chen Y; Shen JZ; Pan Q; Yang W; Yan H; Liu H; Ai W; Liao W; Guo S
J Agric Food Chem; 2019 Apr; 67(13):3651-3661. PubMed ID: 30875211
[TBL] [Abstract][Full Text] [Related]
23. AMPK is not required for the effect of metformin on the inhibition of BMP6-induced hepcidin gene expression in hepatocytes.
Deschemin JC; Foretz M; Viollet B; Vaulont S
Sci Rep; 2017 Oct; 7(1):12679. PubMed ID: 28978947
[TBL] [Abstract][Full Text] [Related]
24. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
[TBL] [Abstract][Full Text] [Related]
25. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway.
Ouedraogo R; Wu X; Xu SQ; Fuchsel L; Motoshima H; Mahadev K; Hough K; Scalia R; Goldstein BJ
Diabetes; 2006 Jun; 55(6):1840-6. PubMed ID: 16731851
[TBL] [Abstract][Full Text] [Related]
26. Metformin stimulates FGF21 expression in primary hepatocytes.
Nygaard EB; Vienberg SG; Ørskov C; Hansen HS; Andersen B
Exp Diabetes Res; 2012; 2012():465282. PubMed ID: 23118742
[TBL] [Abstract][Full Text] [Related]
27. Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice.
Jeong KJ; Kim DY; Quan HY; Jo HK; Kim GW; Chung SH
Fitoterapia; 2014 Mar; 93():150-62. PubMed ID: 24418657
[TBL] [Abstract][Full Text] [Related]
28. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
[TBL] [Abstract][Full Text] [Related]
29. Berberine promotes glucose consumption independently of AMP-activated protein kinase activation.
Xu M; Xiao Y; Yin J; Hou W; Yu X; Shen L; Liu F; Wei L; Jia W
PLoS One; 2014; 9(7):e103702. PubMed ID: 25072399
[TBL] [Abstract][Full Text] [Related]
30. Glucose-dependent regulation of AMP-activated protein kinase in MIN6 beta cells is not affected by the protein kinase A pathway.
Garcia-Haro L; Garcia-Gimeno MA; Neumann D; Beullens M; Bollen M; Sanz P
FEBS Lett; 2012 Nov; 586(23):4241-7. PubMed ID: 23116618
[TBL] [Abstract][Full Text] [Related]
31. AMPK and PKA interaction in the regulation of survival of liver cancer cells subjected to glucose starvation.
Ferretti AC; Tonucci FM; Hidalgo F; Almada E; Larocca MC; Favre C
Oncotarget; 2016 Apr; 7(14):17815-28. PubMed ID: 26894973
[TBL] [Abstract][Full Text] [Related]
32. Metformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: an in vitro study.
Kobashigawa LC; Xu YC; Padbury JF; Tseng YT; Yano N
PLoS One; 2014; 9(8):e104888. PubMed ID: 25127116
[TBL] [Abstract][Full Text] [Related]
33. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis.
Ji X; Wang S; Tang H; Zhang Y; Zhou F; Zhang L; Zhu Q; Zhu K; Liu Q; Liu Y; Wang X; Zhou L
Metabolism; 2019 Sep; 98():62-75. PubMed ID: 31181215
[TBL] [Abstract][Full Text] [Related]
34. Decreased Gluconeogenesis in the Absence of Cystathionine Gamma-Lyase and the Underlying Mechanisms.
Untereiner AA; Wang R; Ju Y; Wu L
Antioxid Redox Signal; 2016 Jan; 24(3):129-40. PubMed ID: 26401978
[TBL] [Abstract][Full Text] [Related]
35. Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats.
Li X; Liu R; Luo L; Yu L; Chen X; Sun L; Wang T; Hylemon PB; Zhou H; Jiang Z; Zhang L
Arch Toxicol; 2017 Jan; 91(1):481-494. PubMed ID: 27090119
[TBL] [Abstract][Full Text] [Related]
36. Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice.
Fujita Y; Hosokawa M; Fujimoto S; Mukai E; Abudukadier A; Obara A; Ogura M; Nakamura Y; Toyoda K; Nagashima K; Seino Y; Inagaki N
Diabetologia; 2010 Jul; 53(7):1472-81. PubMed ID: 20349346
[TBL] [Abstract][Full Text] [Related]
37. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.
O'Brien AJ; Villani LA; Broadfield LA; Houde VP; Galic S; Blandino G; Kemp BE; Tsakiridis T; Muti P; Steinberg GR
Biochem J; 2015 Jul; 469(2):177-87. PubMed ID: 25940306
[TBL] [Abstract][Full Text] [Related]
38. The calcium/CaMKKalpha/beta and the cAMP/PKA pathways are essential upstream regulators of AMPK activity in boar spermatozoa.
Hurtado de Llera A; Martin-Hidalgo D; Gil MC; Garcia-Marin LJ; Bragado MJ
Biol Reprod; 2014 Feb; 90(2):29. PubMed ID: 24389872
[TBL] [Abstract][Full Text] [Related]
39. Dehydroepiandrosterone reduces accumulation of lipid droplets in primary chicken hepatocytes by biotransformation mediated via the cAMP/PKA-ERK1/2 signaling pathway.
Li L; Ge C; Wang D; Yu L; Zhao J; Ma H
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):625-638. PubMed ID: 29571766
[TBL] [Abstract][Full Text] [Related]
40. The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases.
Hasanvand A
Inflammopharmacology; 2022 Jun; 30(3):775-788. PubMed ID: 35419709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
